In a new study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, researchers, including those from the NIHR Leicester Biomedical Research Centre, sought to determine the percentage of COVID-19 patients discharged from the hospital who had a type of fibrotic lung damage, known as interstitial lung disease, that requires ongoing follow-up care. These patients had varying degrees of COVID severity at hospital admission.
COVID-19 admission inspires local graduate to help shape research
In 2020 Rhyan was 22 and had just graduated from university, excited to start his career.Read More
Chief Scientific Adviser visits Leicester
Sir Patrick Vallance, the Government Chief Scientific Adviser, along with Chief Scientific Officers from across government departments, visited the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC) to find out more about Leicester’s clinical research and work to tackle health disparities.Read More
Wearable device study shows the heart health benefits of more intense physical activity
Increasing physical activity of any intensity is beneficial for health, but new research published today in the European Heart Journal shows that there is a greater reduction in cardiovascular disease risk when more of that activity is of at least moderate intensity. The study, led by researchers at the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre and University of Cambridge, analysed wrist-worn accelerometer-measured physical activity data from more than 88,000 UK Biobank participants.
New multimillion investment in Leicester to help turn research discoveries into treatments for patients
Pioneering research into medical advancements in Leicester has received a welcome boost today, as the National Institute for Health and Care Research (NIHR) announces £26 million over the next five years for an NIHR Leicester Biomedical Research Centre (BRC).
£8.8 million to speed up gene discoveries for lung conditions
- New project aims to speed up process of finding treatments for chronic obstructive pulmonary disease (COPD), asthma and pulmonary fibrosis
- Scientists at the University of Leicester, University of Nottingham and University of Cambridge, will connect data science, genomics and laboratory research for the first time in tackling lung conditions
- New genetic markers of lung function to be identified, which will provide new targets for drug development
- Chronic respiratory disease, such as COPD, is the third leading cause of death globally